NASDAQ

Palvella Therapeutics, Inc. (PVLA)

♥ 352 Thanks from members

Live price chart, market sentiment, and community perspectives for Palvella Therapeutics, Inc. (NASDAQ: PVLA).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Palvella Therapeutics Scientific TeamLeadership: Wes Bloom (Chief Executive Officer)Leadership: Chief Medical OfficerHolder: Samsara BioCapitalHolder: Janus Henderson GroupHolder: PerkinElmer VenturesQTORIN rapamycin anhydrous gelRare disease therapeutics pipeline#PVLA#Palvella Therapeutics#rare disease biotech#dermatology therapeutics#Nasdaq PVLA